syncytial virus infections

Respiratory syncytial virus in older adults and people with chronic disorders drives substantial winter morbidity. A Portuguese multisociety position recommends RSV vaccination for adults 60 years and older and for younger high-risk patients, endorses coadm...

In Portugal, respiratory syncytial virus prevention in older adults is advancing as a multi-society position endorses vaccination for adults aged 60 years and older and those with chronic disorders. The consensus emphasizes integration into routine immuniza...

A Portuguese multi-society position consolidates evidence on respiratory syncytial virus infections and recommends RSV vaccination for adults aged >=60 years and for adults with chronic disorders. The guidance addresses eligibility, prioritization when supp...